Drug
C1 Esterase Inhibitor Single Dose
C1 Esterase Inhibitor Single Dose: highest development phase Phase 1/2, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| C1-esterase inhibitor - single intravenous dose NCT01576523 | Phase 1/2 | Hereditary Angioedema Types I and II |
Latest
No recent events.
Follow C1 Esterase Inhibitor Single Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.